{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:02:35Z","timestamp":1769317355695,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dadr.2023.100168","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:28:14Z","timestamp":1684963694000},"page":"100168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada"],"prefix":"10.1016","volume":"7","author":[{"given":"Zachary","family":"Bouck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea C.","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey R.","family":"Banack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5981-8443","authenticated-orcid":false,"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-1653","authenticated-orcid":false,"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Werb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2023.100168_bib0001","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1086\/427475","article-title":"Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment","volume":"40","author":"Backmund","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.dadr.2023.100168_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1094428104263672","article-title":"Using generalized estimating equations for longitudinal data analysis","volume":"7","author":"Ballinger","year":"2004","journal-title":"Organ Res, Methods"},{"key":"10.1016\/j.dadr.2023.100168_bib0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11524-017-0188-4","article-title":"Non-injection drug use and injection initiation assistance among people who inject drugs in Tijuana, Mexico","volume":"95","author":"Ben Hamida","year":"2018","journal-title":"J. Urban Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2015.02.011","article-title":"Factors associated with being asked to initiate someone into injection drug use","volume":"149","author":"Bluthenthal","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0005","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/j.drugalcdep.2014.09.078","article-title":"Factors associated with precursors to initiating other people into injection drug use","volume":"146","author":"Bluthenthal","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107983","article-title":"Recent incarceration and risk of first-time injection initiation assistance: a prospective cohort study of persons who inject drugs","volume":"212","author":"Bouck","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000001443","article-title":"Validation of self-reported opioid agonist treatment among people who inject drugs using prescription dispensation records","volume":"33","author":"Bouck","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.dadr.2023.100168_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103398","article-title":"Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico","volume":"95","author":"Bowles","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0009","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1360-0443.2002.00058.x","article-title":"Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration","volume":"97","author":"Brugal","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100168_bib0010","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.dadr.2023.100168_bib0011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/09595230701247731","article-title":"The gendered context of initiation to injecting drug use: evidence for women as active initiates","volume":"26","author":"Bryant","year":"2007","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.dadr.2023.100168_bib0012","unstructured":"Canadian Research Initiative in Substance Misuse (CRISM), 2018. National guideline for the clinical management of opioid use disorder."},{"key":"10.1016\/j.dadr.2023.100168_bib0013","unstructured":"Centre for Addiction and Mental Health (CAMH), 2021. Opioid agonist therapy: a synthesis of Canadian guidelines for treating opioid use disorder 52."},{"key":"10.1016\/j.dadr.2023.100168_bib0014","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/CLEP.S129728","article-title":"Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators","volume":"9","author":"Corraini","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0016","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1360-0443.1996.918118710.x","article-title":"The first hit: circumstances surrounding initiation into injecting","volume":"91","author":"Crofts","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100168_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jurban\/jtg022","article-title":"Heroin overdose: research and evidence-based intervention","volume":"80","author":"Darke","year":"2003","journal-title":"J. Urban Health: Bull. New York Acad. Med."},{"key":"10.1016\/j.dadr.2023.100168_bib0018","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","article-title":"Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013","volume":"16","author":"Degenhardt","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.dadr.2023.100168_bib0019","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"The Lancet Glob. Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0020","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s10461-019-02467-y","article-title":"Implementing an updated \u201cBreak the Cycle\u201d intervention to reduce initiating persons into injecting drug use in an eastern European and a US \u201copioid epidemic\u201d setting","volume":"23","author":"Des Jarlais","year":"2019","journal-title":"AIDS Behav."},{"key":"10.1016\/j.dadr.2023.100168_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fsoc.2021.619560","article-title":"A multistage process model of how a person who currently injects drugs comes to assist persons who do not inject with their first injections","volume":"6","author":"Des Jarlais","year":"2021","journal-title":"Front. Sociol."},{"key":"10.1016\/j.dadr.2023.100168_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.9795","article-title":"Clinical management of opioid use disorder","volume":"316","author":"Dunlap","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2023.100168_bib0023","doi-asserted-by":"crossref","first-page":"E1049","DOI":"10.1503\/cmaj.190344","article-title":"Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline","volume":"191","author":"Fairbairn","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.dadr.2023.100168_bib0024","unstructured":"Fox, M.P., MacLehose, R.F., Lash, T.L., 2022. Record level probabilistic bias analysis \u2013 SAS code [WWW Document]. Google Docs. URL https:\/\/drive.google.com\/file\/d\/11fSicPHUfFy2x6evmTRf26awnmDuwF-1\/view (accessed 3.25.22)."},{"key":"10.1016\/j.dadr.2023.100168_bib0025","series-title":"Applying Quantitative Bias Analysis to Epidemiologic Data","first-page":"291","article-title":"Probabilistic bias analysis for simulation of record-level data","author":"Fox","year":"2021"},{"key":"10.1016\/j.dadr.2023.100168_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2006.12.021","article-title":"Gender differences in injection risk behaviors at the first injection episode","volume":"89","author":"Frajzyngier","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0027","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.dadr.2023.100168_bib0028","doi-asserted-by":"crossref","unstructured":"Garfein, R.S., Vlahov, D., Doherty, M.C., Nelson, K.E., 1996. Human immunodeficiency, and human T-lymphotropic viruses 86, 7.","DOI":"10.2105\/AJPH.86.5.655"},{"key":"10.1016\/j.dadr.2023.100168_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/epirev\/mxaa008","article-title":"Prevalence and correlates of providing and receiving assistance with the transition to injection drug use","volume":"42","author":"Gicquelais","year":"2020","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.dadr.2023.100168_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10900-010-9231-z","article-title":"Circumstances, pedagogy and rationales for injection initiation among new drug injectors","volume":"35","author":"Goldsamt","year":"2010","journal-title":"J. Community Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.dadr.2023.100168_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","author":"Greenland","year":"2016","journal-title":"BMJ i1981"},{"key":"10.1016\/j.dadr.2023.100168_bib0033","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/add.13957","article-title":"The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis","volume":"112","author":"Guise","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100168_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2018.02.009","article-title":"A fragmented code: the moral and structural context for providing assistance with injection drug use initiation in San Diego, USA","volume":"55","author":"Guise","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.drugpo.2008.06.003","article-title":"New injectors and the social context of injection initiation","volume":"20","author":"Harocopos","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0036","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1198\/016214501753168154","article-title":"Marginal structural models to estimate the joint causal effect of nonrandomized treatments","volume":"96","author":"Hern\u00e1n","year":"2001","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.dadr.2023.100168_bib0037","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/sim.1144","article-title":"Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures","volume":"21","author":"Hern\u00e1n","year":"2002","journal-title":"Statist. Med."},{"key":"10.1016\/j.dadr.2023.100168_bib0038","series-title":"Causal Inference: What if","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/j.dadr.2023.100168_bib0039","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/EDE.0000000000000409","article-title":"Selection bias due to loss to follow up in cohort studies","volume":"27","author":"Howe","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.dadr.2023.100168_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: the role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0041","first-page":"e1229","article-title":"The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review","volume":"2","author":"Karki","year":"2016","journal-title":"Evid. Based Med. Public Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0042","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/aje\/kwx311","article-title":"Analysis of longitudinal studies with repeated outcome measures: adjusting for time-dependent confounding using conventional methods","volume":"187","author":"Keogh","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","article-title":"Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver","volume":"80","author":"Kerr","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0044","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/16066350802011664","article-title":"A qualitative study on the initiation into injection drug use: necessary and background processes","volume":"17","author":"Khobzi","year":"2009","journal-title":"Addict. Res. Theory"},{"key":"10.1016\/j.dadr.2023.100168_bib0045","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/10826084.2015.1023456","article-title":"Initiation stories: an examination of the narratives of people who assist with a first injection","volume":"50","author":"Kolla","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2023.100168_bib0046","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"Larney","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0047","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.addbeh.2016.08.041","article-title":"Income generation and attitudes toward addiction treatment among people who use illicit drugs in a Canadian setting","volume":"64","author":"Luongo","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.dadr.2023.100168_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002973","article-title":"Opioid agonist treatment scale-up and the initiation of injection drug use: a dynamic modeling analysis","volume":"16","author":"Marks","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.dadr.2023.100168_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108829","article-title":"The impact of recent homelessness on the provision of injection drug use initiation assistance among persons who inject drugs in Tijuana, Mexico and Vancouver, Canada","volume":"225","author":"Marks","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046957","article-title":"Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings","volume":"11","author":"Marks","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.dadr.2023.100168_bib0051","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.dadr.2023.100168_bib0052","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugalcdep.2017.10.009","article-title":"Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings","volume":"182","author":"Melo","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0053","article-title":"Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada","author":"Meyers-Pantele","year":"2021","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.dadr.2023.100168_bib0054","doi-asserted-by":"crossref","unstructured":"Meyers-Pantele, S.A., Mittal, M.L., Jain, S., Sun, S., Rammohan, I., Fairbairn, N., Milloy, M.-J., DeBeck, K., Hayashi, K., Werb, D., 2022. The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance 7.","DOI":"10.1186\/s13011-022-00470-6"},{"key":"10.1016\/j.dadr.2023.100168_bib0055","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1080\/10826084.2019.1648514","article-title":"Another person was going to do it\u201d: the provision of injection drug use initiation assistance in a high-risk U.S.-Mexico border region","volume":"54","author":"Mittal","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2023.100168_bib0056","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drugalcdep.2018.12.018","article-title":"Opioid agonist treatment and the process of injection drug use initiation","volume":"197","author":"Mittal","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0057","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13011-017-0126-1","article-title":"History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA","volume":"12","author":"Mittal","year":"2017","journal-title":"Subst. Abuse Treat Prev. Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0058","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1106","article-title":"Missing confounding data in marginal structural models: a comparison of inverse probability weighting and multiple imputation","volume":"4","author":"Moodie","year":"2008","journal-title":"Int. J. Biostat."},{"key":"10.1016\/j.dadr.2023.100168_bib0059","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1080\/10826084.2019.1608252","article-title":"Factors associated with frequency of recent initiation of others into injection drug use among people who inject drugs in Los Angeles and San Francisco, CA, USA, 2016-17","volume":"54","author":"Navarro","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2023.100168_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13011-020-00323-0","article-title":"Non-fatal overdose among people who inject drugs in Tehran, Iran","volume":"15","author":"Noroozi","year":"2020","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0061","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugpo.2019.04.004","article-title":"Navigating social norms of injection initiation assistance during an overdose crisis: a qualitative study of the perspectives of people who inject drugs (PWID) in Vancouver, Canada","volume":"69","author":"Olding","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0062","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2023.100168_bib0063","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.drugpo.2011.07.012","article-title":"Narrating the social relations of initiating injecting drug use: transitions in self and society","volume":"22","author":"Rhodes","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0064","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/ije\/dyv137","article-title":"Standardized binomial models for risk or prevalence ratios and differences","volume":"44","author":"Richardson","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.dadr.2023.100168_bib0066","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10461-013-0693-8","article-title":"Transition to injection drug use: the role of initiators","volume":"18","author":"Rotondi","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.dadr.2023.100168_bib0067","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jclinepi.2016.05.017","article-title":"Propensity score model overfitting led to inflated variance of estimated odds ratios","volume":"80","author":"Schuster","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107885","article-title":"Reasons for assisting with injection initiation: results from a large survey of people who inject drugs in Los Angeles and San Francisco, California","volume":"209","author":"Simpson","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0069","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1747-597X-4-8","article-title":"Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study","volume":"4","author":"Small","year":"2009","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0070","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/liv.14043","article-title":"Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting","volume":"39","author":"Soc\u00edas","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.dadr.2023.100168_bib0071","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","article-title":"Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006\u20132016","volume":"189","author":"Soc\u00edas","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2017.03.008","article-title":"Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: an interrupted time series analysis","volume":"45","author":"Soc\u00edas","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2023.100168_bib0073","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.01.004","article-title":"Interrupting the social processes linked with initiation of injection drug use: results from a pilot study","volume":"137","author":"Strike","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0074","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(97)10101-5","article-title":"Death from heroin overdose: findings from hair analysis","volume":"351","author":"Tagliaro","year":"1998","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.dadr.2023.100168_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2018.03.048","article-title":"Frequency and factors associated with providing injection initiation assistance in Tallinn","volume":"188","author":"Uusk\u00fcla","year":"2018","journal-title":"Estonia. Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100168_bib0076","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/oxfordjournals.aje.a008752","article-title":"Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users","volume":"143","author":"van Haastrecht","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0077","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ije\/dyz251","article-title":"Reflection on modern methods: five myths about measurement error in epidemiological research","volume":"49","author":"van Smeden","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.dadr.2023.100168_bib0078","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1037\/a0022610","article-title":"A marginal structural model analysis for loneliness: implications for intervention trials and clinical practice","volume":"79","author":"VanderWeele","year":"2011","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.dadr.2023.100168_bib0079","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12954-017-0135-4","article-title":"The North American opioid epidemic: current challenges and a call for treatment as prevention","volume":"14","author":"Vashishtha","year":"2017","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2023.100168_bib0080","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2014 Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2023.100168_bib0081","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11524-017-0192-8","article-title":"Preventing injection drug use initiation: state of the evidence and opportunities for the future","volume":"95","author":"Werb","year":"2018","journal-title":"J. Urban Health"},{"key":"10.1016\/j.dadr.2023.100168_bib0082","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-016-0114-1","article-title":"A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study","volume":"13","author":"Werb","year":"2016","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2023.100168_bib0083","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10826084.2019.1669660","article-title":"Initiating persons into injection drug use in rural West Virginia, USA","volume":"55","author":"White","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2023.100168_bib0084","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/10826080600669561","article-title":"Motives for and against injecting drug use among young adults in Amsterdam: qualitative findings and considerations for disease prevention","volume":"41","author":"Witteveen","year":"2006","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2023.100168_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103601","article-title":"Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada","volume":"102","author":"Young","year":"2022","journal-title":"Int. J. Drug Policy"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:35:31Z","timestamp":1757421331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724623000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":85,"alternative-id":["S2772724623000380"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100168","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100168"}}